Federal R&D, Drug Discovery, and Pricing Insights from the NIH-University-Industry Relationship

Format:

Book

Government document

Author/Creator:

Library of Congress. Congressional Research Service. Resources, Science, and Industry Division

Language:

English

Subjects (All):

Medicine--Research.

Medicine.

Pharmaceutical industry.

Price regulation.

Physical Description:

1 online resource

Contained In:

ProQuest U.S. Congressional Research Digital Collection

Place of Publication:

[United States] [publisher not identified] 2011

Summary:

Explores reasons behind Government funding of R&D and subsequent efforts to facilitate private sector commercialization of the results of such work. Examines the manner in which NIH supports research to encourage the development of new pharmaceuticals and therapeutics through cooperative activities with academia, industry, and Government. Discusses whether or not use of the results of Federal R&D enterprise warrants Government input into price decisions made by the private sector. Addresses concerns surrounding innovation in health-related areas within context of Government role in facilitating technological progress

Notes:

CRS Report

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Jan. 2013). Reuse except for individual research requires license from ProQuest, LLC

Vendor supplied data

Other Format:

Microfiche version Library of Congress. Congressional Research Service. Resources, Science, and Industry Division. Federal R&D, Drug Discovery, and Pricing

Publisher Number:

CRS-2011-RSI-0402

Access Restriction:

Restricted for use by site license